1. Grace S, Rogers S, Eddy S.. The natural medicine workforce: Terms in public use. JATMS. 2011;17(3):139–42.
2. Fulder SJ, Munro RE.. Complementary medicine in the United Kingdom: Patient practitioners, and consultations. Lancet. 1985;2:252–545.[PubMed]
3. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M.. Trends in alternative medicine use in the United States, 1990–1997. JAMA. 1998. 280(18):1569–75.[PubMed]
4. Australian Bureau of Statistics. Canberra: Australian Bureau of Statistics; 2008. Australian social trends: Complementary therapies.
5. MacLennan AH, Myers SP, Taylor AW.. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust. 2006 Jan 2;184(1):27–31.[PubMed]
6. Sirois FM, Gick ML.. An investigation of the health beliefs and motivations of complementary medicine clients. Soc Sci Med. 2002;55(6):1025–37.[PubMed]
7. Leung S, Chan K, Song L.. Publishing trends in Chinese medicine and related subjects documented in WorldCat. Health Information & Libraries Journal. 2006;23(1):13–22.[PubMed]
8. Han JS, Ho YS.. Global trends and performances of acupuncture research. Neurosci Biobehav Rev. 2011;35(3):680–7.[PubMed]
9. Barnes PM, Bloom B, Nahin RL.. Complementary and alternative medicine use among adults and children: United States, 2007. 2008 National Health Statistics Reports; no 12. Hyattsville, MD: National Center for Health Statistics. [PubMed]
10. Barnes J, Abbot NC, Harkness EF, Ernst E.. Articles on complementary medicine in the mainstream medical literature: An investigation of MEDLINE, 1966 through 1996. Arch Intern Med. 1999 Aug 9–23;159(15):1721–5.[PubMed]
11. Barnes PM, Powell-Griner E, McFann K, Nahin RL.. Complementary and alternative medicine use among adults: United States, 2002. Semin Integr Med. 2004 May 27;2(2):54–71.
12. Tovey P, Easthope G, Adams J. Routledge; 2004. The mainstreaming of complementary and alternative medicine: Studies in social context.
13. Goldner M.. Integrative medicine: issues to consider in this emerging form of health care. Res Sociol Health Care. 2000;17:213–33.
14. Langone J.. Challenging the mainstream. Time. 1996;40(3)[PubMed]
15. Dranov P.. Alternative medicine: What helps, what hurts. LHG. 1996 Nov;:94–9.
16. White J.. Alternative sports medicine. Physician Sports Med. 1998;26:92–105.[PubMed]
17. Koh B.. Athlete motivation and healthcare choices: A study into factors influencing athletes use of conventional, complementary and alternative medicine in Australia. 2008 Unpublished research. University of Technology Sydney.
18. Koh B, Freeman L, Jonson P, Zaslawski C. Australia: Department of Health and Ageing, Australian government; 2010. Culture, knowledge, ‘Spirit of Sport’: Understanding alternative therapy use and doping in aquatic-sports.
19. Fédération Internationale de Natation (FINA) Constitution 2009–2013. FINA Handbook 2009–2013 [serial on the Internet]. 2009: Available from: http://www.fina.org/project/index.php?option=com_content&task=view&id=42&Itemid=119.
20. World Anti-Doping Agency. The 2011 Prohibited List2011; (1 January 2011): Available from: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2011_EN.pdf.
21. World Anti-Doping Agency. The 2012 Prohibited List: Effective 1 Jan 20122011; (24 August 2011): Available from: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2012_EN.pdf.
22. World Anti-Doping Agency. World anti-doping code 2009: Available from: http://www.wada-ama.org/rtecontent/document/code_v2009_En.pdf.
23. Santow S. Australia: ABC Local Radio; 2008. Blood doping on the rise. The World Today.
24. McLauchlan GJ, Handoll HH.. Interventions for treating acute and chronic achilles tendinitis. Cochrane Database Syst Rev. 2001 2(CD000232) [PubMed]
25. Lee P, Kwan A, Nokes L.. Actovegin: Cutting-edge sports medicine or “voodoo” remedy? Current Sports Medicine Reports. 2011;10(4):186–90.[PubMed]
26. World Anti-Doping Agency. The 2008 Prohibited List2008; (1 January 2008): Available from: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2008_EN.pdf.
27. Ritchie D, Morrissey T.. Manly admits to cows' blood injections. The Daily Telegraph. 2008. 2008 Jul 3;
28. Tsitsimpikou C, Tsiokanos A, Tsarouhas K, Schamasch P, Fitch KD, Valasiadis D, Jamurtas A.. Medication use by athletes at the Athens 2004 summer Olympic games. Clin J Sport Med. 2009;19(1):33–8.[PubMed]
29. Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P, Kelberine F, Kon E, Maffulli N, Matheson G, Mei-Dan O, Menetrey J, Philippon M, Randelli P, Schamasch P, Schwellnus M, Vernec A, Verrall G.. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med. 2010. 2010 Dec 1;44(15):1072–81.[PubMed]
30. Blackwell T.. Canadian doctor in sports-doping scandal has been unfairly punished, lawyer says. National Post. 2011 Dec 7
31. World Anti-Doping Agency. Questions & answers on 2012 prohibited list: What is the status of actovegin? 2011 [updated September; cited 2011 28 December]; Available from: http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/QA-on-2012-Prohibited-List/
32. Sillup M.. Roche says it didn't add molecule to drug found in cyclist test Bloomberg News. 2008. 2008 Jul 23;
33. Salleh A.. Athletes' caffeine use reignites scientific debate. ABC News. 2008. 2008 Aug 2;
34. Barrett D.. Woods's doctor to face drug charges. The Sydney Morning Herald. 2009. 2009 Dec 18;
35. Koh B, Freeman L, Jonson P, Zaslawski C. Liverpool, UK: 2009. Athlete healthcare behaviour: An ethnographer's methodological conundrum. The 4th annual joint University of Liverpool Management School and Keele University Institute for Public Policy and Management Symposium on Current Developments in Ethnographic Research in the Social and Management Sciences.
36. Mayer DJ.. Acupuncture: An evidence-based review of the clinical literature. Annu Rev Med. 2000;51(1):49–63.[PubMed]
37. Langevin HM, Yandow JA.. Relationship of acupuncture points and meridians to connective tissue planes. Anat Rec. 2002;269(6):257–65.[PubMed]
38. Caspi O, Koithan M, Criddle MW.. Alternative medicine or alternative patients: A qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Making. 2004. 2004 Jan 1;24(1):64–79.[PubMed]
39. Wang SM, Kain ZN, White P.. Acupuncture analgesia: I. The scientific basis. Anesth Analg. 2008;106(2):602–10.[PubMed]
40. Han JS.. Acupuncture: Neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci. 2003;26(1):17–22.[PubMed]
41. Pomeranz B.. Scientific research into acupuncture for the relief of pain. J Altern Complement Med. 1996;2(1):53–60.[PubMed]
42. Li A, Lao L, Wang Y, Xin J, Ren K, Berman B. et al. Electroacupuncture activates corticotrophin-releasing hormone-containing neurons in the paraventricular nucleus of the hypothalammus to alleviate edema in a rat model of inflammation. BMC Complement Altern Med. 2008;8(1):20.[PMC free article][PubMed]
43. Dhond RP, Kettner N, Napadow V.. Neuroimaging acupuncture effects in the human brain. J Altern Complement Med. 2007;13(6):603–16.[PubMed]
44. Harris RE, Zubieta JK, Scott DJ, Napadow V, Gracely RH, Clauw DJ.. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on [mu]-opioid receptors (MORs) Neuroimage. 2009;47(3):1077–85.[PMC free article][PubMed]
45. Langevin HM, Churchill DL, Wu J, Badger GJ, Yandow JA, Fox JR. et al. Evidence of connective tissue involvement in acupuncture. The FASEB journal. 2002;16(8):872.[PubMed]
46. Goldman N, Chen M, Fujita T, Xu Q, Peng W, Liu W. et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci. 2010. 13(7):883–8.[PMC free article][PubMed]
47. Sandberg M, Lundeberg T, Lindberg LG, Gerdle B.. Effects of acupuncture on skin and muscle blood flow in healthy subjects. Eur J Appl Physiol. 2003;90(1):114–9.[PubMed]
48. Ahmedov S.. Ergogenic effect of acupuncture in sport and exercise: A brief review. JSCR. 2010;24(5):1421–7.[PubMed]
49. Schwanitz R.. Acupuncture and related methods spplied in sports medicine: Exemplified by the rupture of a muscle fiber. Medical Acupuncture. 2007;19(2):105–8.
50. Pelham T, Holt L, Stalker R.. Acupuncture in human performance. The Journal of Strength and Conditioning Research. 2001;15(2):266–71.[PubMed]
51. Cowley M.. Get set for another record & the world record for world records. The Sydney Morning Herald. 2008. 2008 Aug 14;
52. The Associated Press. Jun 4, 2008. FINA approves new swimsuits from Arena, Adidas and Mizuno. International Herald Tribune. 2008.
53. Pearce N.. Olympic swimming records set to tumble at London 2012 as Speedo unveil Fastskin3 swimwear system. The Telegraph. 2011 Nov 30
54. Fédération Internationale de Natation (FINA) Swimming Rules SW 10.8. FINA Handbook 2009–2013 [serial on the Internet]. 2009: Available from: http://www.fina.org/project/index.php?option=com_content&task=view&id=45&Itemid=119.
55. Bair YA, Gold EB, Zhang G, Rasor N, Utts J, Upchurch DM, Chyu L, Greendale GA, Sternfeld B, Adler SR.. Use of complementary and alternative medicine during the menopause transition: Longitudinal results from the Study of Women's Health Across the Nation. Menopause. 2008;15(1):32–43.[PubMed]
56. Vlieger AM. Amsterdam: University of Amsterdam; 2009. Complementary therapies in paediatric gastroenterology: Prevalence, safety and efficacy studies.
57. Jones L, Sciamanna C, Lehman E.. Are those who use specific complementary and alternative medicine therapies less likely to be immunized? Prev Med. 2010;50(3):148–54.[PubMed]
58. Nichol J, Thompson EA, Shaw A.. Beliefs, decisionmaking, and dialogue about complementary and alternative medicine (CAM) within families using CAM: A qualitative study. J Altern Complement Med. 2011;17(2):117–25.[PubMed]
59. Chao M, Wade C, Kronenberg F.. Disclosure of complementary and alternative medicine to conventional medical providers: Variation by race/ethnicity and type of CAM. J Natl Med Assoc. 2008;100(11):1341.[PMC free article][PubMed]
60. Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D.. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004;90(2):408–13.[PMC free article][PubMed]
61. Stevenson FA, Britten N, Barry CA, Bradley CP, Barber N.. Self-treatment and its discussion in medical consultations: how is medical pluralism managed in practice? Soc Sci Med. 2003;57(3):513–27.[PubMed]
62. London AS, Foote-Ardah CE, Fleishman JA, Shapiro MF.. Use of alternative therapists among people in care for HIV in the United States. Am J Public Health. 2003;93(6):980–7.[PMC free article][PubMed]
63. Kitai E, Shlomo V, Sandiuk A, Hornik O, Zeltcer C, Gaver A.. Use of complementary and alternative medicine among primary care patients. Fam Pract. 1998;15(9):411–4.[PubMed]
64. Murray J, Shepherd S.. Alternative or additional medicine? An exploratory study in general practice. Soc Sci Med. 1993;37(8):983–8.[PubMed]
1. Baron DA, Martin DM, Abol Magd S. Doping in sports and its spread to at-risk populations: an international review. World Psychiatry. 2007;6:118–123.[PMC free article][PubMed]
2. Catlin DH, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA. 1996;276:231–237.[PubMed]
3. Fernandez MM, Hosey RG. Performance-enhancing drugs snare nonathletes, too. J Fam Pract. 2009;58:16–23.[PubMed]
4. Metzl JD, Small E, Levine SR, Gershel JC. Creatine use among young athletes. Pediatrics. 2001;108:421–425.[PubMed]
5. Uvacsek M, Nepusz T, Naughton DP, Mazanov J, Ranky MZ, Petroczi A. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes. Scand J Med Sci Sports. 2011;21:224–234.[PubMed]
6. National Institute on Drug Abuse, US Department of Health and Human Services Monitoring the future national survey on drug use, 1975–2003, volume II. College students and adults ages 19–25. [Accessed June 12, 2014]. Available from: http://www.monitoringthefuture.org/pubs/monographs/vol2_2003.pdf.
7. Green GA, Uryasz FD, Petr TA, et al. NCAA study of substance abuse habits of college student-athletes. Clin J Sports Med. 2001;11:51–56.[PubMed]
8. Kersey RD, Elliot DL, Goldberg L, et al. National Athletic Trainers’ Association position statement: anabolic-androgenic steroids. J Athl Train. 2012;47:567–588.[PMC free article][PubMed]
9. Cottler LB, Abdallah AB, Cummings SM, Barr J, Banks R, Forchheimer R. Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug Alcohol Depend. 2011;116:188–194.[PMC free article][PubMed]
10. McDuff DR, Baron D. Substance use in athletics: a sports psychiatry perspective. Clin Sports Med. 2005;24:885–897.[PubMed]
11. Wanjek B, Rosendahl J, Strauss B, Gabriel HH. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med. 2007;28:346–353.[PubMed]
12. Botre F, Pavan A. Enhancement drugs and the athlete. Phys Med Rehabil Clin N Am. 2009;20:133–148.[PubMed]
13. Morse ED. Substance use in athletes. In: Baron DA, Reardon CL, Baron SH, editors. Clinical Sports Psychiatry: An International Perspective. Oxford, UK: Wiley; 2013.
14. Reardon CL, Factor RM. A systematic review of diagnosis and medical treatment of mental illness in athletes. Sports Med. 2010;40:961–980.[PubMed]
15. Riggs P, Levin F, Green AI, et al. Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abuse. 2008;29:51–63.[PubMed]
16. Baron DA, Reardon CL, Baron SH. Doping in sport. In: Baron DA, Reardon CL, Baron SH, editors. Clinical Sports Psychiatry: An International Perspective. Oxford, UK: Wiley; 2013.
17. Yesalis CE. History of doping in sport. In: Bahrke MS, Yesalis CE, editors. Performance Enhancing Substances in Sport and Exercise. Champaign, IL, USA: Human Kinetics; 2002.
18. Landry GL, Kokotailo PK. Drug screening in athletic settings. Curr Problems Pediatr. 2004;24:344–359.[PubMed]
19. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic. Clin Chem. 1997;43:1262–1279.[PubMed]
20. McGann B, McGann C. The Story of the Tour de France. Indianapolis, IN, USA: Dog Ear Publishing; 2006.
21. Teale P, Scarth J, Judson S. Impact of the emergence of designer drugs upon sports doping testing. Bioanalysis. 2012;4:71–88.[PubMed]
22. International Association of Athletics Federations IAAF commitment to healthy and drug free athletic. 2013. [Accessed August 29, 2013]. Available from: http://www.iaaf.org/about-iaaf/medical-anti-doping.
23. Federation Internationale de Football Association A brief history of doping. 2013. [Accessed August 29, 2013]. Available from: http://www.fifa.com/aboutfifa/footballdevelopment/medical/news/newsid=514062/index.html.
24. International Olympic Committee Factsheet: the fight against doping and promotion of athletes’ health. 2013. [Accessed August 29, 2013]. Available from: http://www.olympic.org/Documents/Reference_documents_Factsheets/Fight_against_doping.pdf.
25. World Anti-Doping Agency A brief history of anti-doping. 2010. [Accessed August 29, 2013]. Available from: http://www.wada-ama.org/en/about-wada/history/
26. Voet W. Breaking the Chain. London, UK: Random House; 1999.
27. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.[PubMed]
28. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281:E1172–E1181.[PubMed]
29. Storer TW, Magliano L, Woodhouse L, et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003;88:1478–1485.[PubMed]
30. Wallace MB, Lim J, Cutler A, Bucci L. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999;31:1788–1792.[PubMed]
31. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol. 1998;49:421–432.[PubMed]
32. Kohler M, Thomas A, Geyer H, Petrou M, Schanzer W, Thevis M. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. Drug Test Anal. 2010;2:533–537.[PubMed]
33. Handelsman DJ. Clinical review: the rationale for banning human chorionic gonadotropin and estrogen blockers in sport. J Clin Endocrinol Metab. 2006;91:1646–1653.[PubMed]
34. Handelsman DJ. Indirect androgen doping by oestrogen blockage in sports. Br J Pharmacol. 2008;154:598–605.[PMC free article][PubMed]
35. Basaria S. Androgen abuse in athletes: detection and consequences. J Clin Endocrinol Metab. 2010;95:1533–1543.[PubMed]
36. Meinhardt U, Nelson AE, Hansen JL, et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann Intern Med. 2010;152:568–577.[PubMed]
37. Holt RI, Sonksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol. 2008;154:542–556.[PMC free article][PubMed]
38. Eichner ER. Stimulants in sports. Curr Sports Med Rep. 2008;7:244–245.[PubMed]
39. Higgins P, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc. 2010;85:1033–1041.[PMC free article][PubMed]
40. National College Athletic Association NCAA guidelines to document ADHD treatment with banned stimulant medications. Addendum to the Jan 2009 guideline. 2010. [Accessed June 12, 2014]. Available from: http://www.lagrange.edu/resources/pdf/athletics/athletictraining/FAQ.pdf.
41. Shaikin B. Los Angeles Times. Baseball’s 2008 drug test results released in report. Jan 10, 2009. [Accessed September 17, 2010]. Available from: http://articles.latimes.com/2009/jan/10/sports/sp-newswire10.
42. Judkins C, Prock P. Supplements and inadvertent doping – how big is the risk to athletes. Med Sports Sci. 2012;59:143–152.[PubMed]
43. Kendall KL, Smith AE, Graef JL, et al. Effects of four weeks of high-intensity interval training and creatine supplementation on critical power and anaerobic working capacity in college-aged men. J Strength Cond Res. 2009;23:1663–1669.[PubMed]
44. Branch JD. Effect of creatine supplementation on body composition and performance: a meta-analysis. Int J Sport Nutr Exerc Metab. 2003;13:198–226.[PubMed]
45. Elliott S. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol. 2008;154:529–541.[PMC free article][PubMed]
46. Bailey JA, Averbuch RN, Gold MS. Cosmetic psychiatry: from Viagra to MPH. Directions in Psychiatry. 2009;29:1–13.
47. Kindermann W. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes? Sports Med. 2007;37:95–102.[PubMed]
48. Davis E, Loiacono R, Summers RJ. The rush to adrenaline: drugs in sport acting on the beta-adrenergic system. Br J Pharmacol. 2008;154:584–597.[PMC free article][PubMed]
49. Bougault V, Boulet LP. Is there a potential link between indoor chlorinated pool environment and airway remodeling/inflammation in swimmers? Expert Rev Respir Med. 2012;6:469–471.[PubMed]
50. World Anti-Doping Agency The World Anti-Doping Code: The 2013 Prohibited List International Standard. 2013. [Accessed August 23, 2013]. Available from: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf.
51. Petroczi A, Naughton DP. Potentially fatal new trend in performance enhancement: a cautionary note on nitrate. J Int Soc Sports Nutr. 2010;7:25.[PMC free article][PubMed]
52. Watson P, Hasegawa H, Roelands B, Piacentini MF, Looverie R, Meeusen R. Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol. 2005;565(Pt 3):873–883.[PMC free article][PubMed]
53. Schmitt L, Millet G, Robach P, et al. Influence of “living high-training low” on aerobic performance and economy of work in elite athletes. Eur J Appl Physiol. 2006;97:627–636.[PubMed]
54. Vardy J, Judge K. Can knowledge protect against acute mountain sickness? J Public Health. 2005;27:366–370.[PubMed]
55. Suedekum NA, Dieff R. Iron and the athlete. Curr Sports Med Rep. 2005;4:199–202.[PubMed]
56. Maughan RJ, Shirreffs SM. Nutrition for sports performance: issues and opportunities. Proc Nutr Soc. 2012;71:112–119.[PubMed]
57. Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. N Engl J Med. 1999;340:814–815.[PubMed]
58. Edmunds JW, Jayapalan S, DiMarco NM, Saboorian MH, Aukema HM. Creatine supplementation increases renal disease progression in Han:SPRD-cy rats. Am J Kidney Dis. 2001;37:73–78.[PubMed]
59. Saugy M, Avois L, Saudan C, et al. Cannabis and sport.